Surfixdx
1 known investors
Surfix develops a photonic diagnostics platform, combining a photonic biosensor chip with microfluidic cartridges and a desktop reader, to enable point-of-care testing for disease detection and monitoring. The platform is co-developed with partners for applications including drug development, antibiotic susceptibility testing, and diagnosis of conditions such as cancer and cardiovascular disease.
Investors · 1
Frequently asked questions
- What does Surfixdx do?
- Surfix develops a photonic diagnostics platform, combining a photonic biosensor chip with microfluidic cartridges and a desktop reader, to enable point-of-care testing for disease detection and monitoring. The platform is co-developed with partners for applications including drug development, antibiotic susceptibility testing, and diagnosis of conditions such as cancer and cardiovascular disease.
- Who are Surfixdx's investors?
- Surfixdx's investors include PhotonVentures.